Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay L Double

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
NPJ Parkinson'S Disease|June 27, 2017
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's diseaseDominic J Hare, Bárbara Rita Cardoso, Erika P Raven, et al.
Frontiers in Aging Neuroscience|December 10, 2016
Decline in Proliferation and Immature Neuron Markers in the Human Subependymal Zone during Aging: Relationship to EGF- and FGF-Related TranscriptsChristin Weissleder, Samantha J Fung, Matthew W Wong, et al.
Biochemical Pharmacology|August 9, 2003
Iron-binding characteristics of neuromelanin of the human substantia nigraKay L Double, Manfred Gerlach, Volker Schünemann, et al.
Analytical Chemistry|May 29, 2015
Comparative Study of Metal Quantification in Neurological Tissue Using Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry Imaging and X-ray Fluorescence MicroscopyKatherine M Davies, Dominic J Hare, Sylvain Bohic, et al.
Neurobiology of Aging|August 29, 2012
Trophic factors differentiate dopamine neurons vulnerable to Parkinson's diseaseStefanie Reyes, Yuhong Fu, Kay L Double, et al.
Metallomics : Integrated Biometal Science|September 26, 2017
Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brainSian Genoud, Blaine R Roberts, Adam P Gunn, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 13, 2014
Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease)Gabrielle Todd, Miranda Haberfield, Patrick L Faulkner, et al.
Hormones and Behavior|March 10, 2015
Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male ratsTertia D Purves-Tyson, Danny Boerrigter, Katherine Allen, et al.
Archives of Neurology|April 23, 2003
Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification testKay L Double, Dominic B Rowe, Michael Hayes, et al.
Brain Pathology (Zurich, Switzerland)|April 30, 2019
Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's diseaseSophie Virachit, Kathryn J Mathews, Veronica Cottam, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
NPJ Parkinson'S Disease|June 27, 2017
Excessive early-life dietary exposure: a potential source of elevated brain iron and a risk factor for Parkinson's diseaseDominic J Hare, Bárbara Rita Cardoso, Erika P Raven, et al.
Frontiers in Aging Neuroscience|December 10, 2016
Decline in Proliferation and Immature Neuron Markers in the Human Subependymal Zone during Aging: Relationship to EGF- and FGF-Related TranscriptsChristin Weissleder, Samantha J Fung, Matthew W Wong, et al.
Biochemical Pharmacology|August 9, 2003
Iron-binding characteristics of neuromelanin of the human substantia nigraKay L Double, Manfred Gerlach, Volker Schünemann, et al.
Analytical Chemistry|May 29, 2015
Comparative Study of Metal Quantification in Neurological Tissue Using Laser Ablation-Inductively Coupled Plasma-Mass Spectrometry Imaging and X-ray Fluorescence MicroscopyKatherine M Davies, Dominic J Hare, Sylvain Bohic, et al.
Neurobiology of Aging|August 29, 2012
Trophic factors differentiate dopamine neurons vulnerable to Parkinson's diseaseStefanie Reyes, Yuhong Fu, Kay L Double, et al.
Metallomics : Integrated Biometal Science|September 26, 2017
Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brainSian Genoud, Blaine R Roberts, Adam P Gunn, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|August 13, 2014
Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease)Gabrielle Todd, Miranda Haberfield, Patrick L Faulkner, et al.
Hormones and Behavior|March 10, 2015
Testosterone attenuates and the selective estrogen receptor modulator, raloxifene, potentiates amphetamine-induced locomotion in male ratsTertia D Purves-Tyson, Danny Boerrigter, Katherine Allen, et al.
Archives of Neurology|April 23, 2003
Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification testKay L Double, Dominic B Rowe, Michael Hayes, et al.
Brain Pathology (Zurich, Switzerland)|April 30, 2019
Levels of glial cell line-derived neurotrophic factor are decreased, but fibroblast growth factor 2 and cerebral dopamine neurotrophic factor are increased in the hippocampus in Parkinson's diseaseSophie Virachit, Kathryn J Mathews, Veronica Cottam, et al.
Pageof 6